Cite
HARVARD Citation
Tan, D. et al. (2019). Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trial. HIV research & clinical practice. 20 (6), pp. 140-150. [Online].